Cohance Lifesciences
COHANCENSE

Cohance Lifesciences

₹460.004.05 (0.89%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
455.00
Today’s high
476.50
52 week low
266.70
52 week high
1,038.90
Open price
458.60
Previous close
455.95
Live volume
21,94,523
Lower circuit
364.80
Upper circuit
547.10

Fundamentals

Market Cap
₹17,456Cr
ROE
5.05%
P/E Ratio(TTM)
298.20
EPS(TTM)
1.53
P/B Ratio
4.46
Dividend Yield
0.00%
Industry P/E
38.07
Book Value
102.23
Debt to Equity
0.10
Face Value
1

Financial performance

Quarterly
Yearly
All Financials
JUN '26
Revenue (Cr)
₹435
-29.61%
Profit (Cr)
-₹45.19
-643.80%
-2000250500750
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)-23%
3Y CAGR+18%
Profit growthValue
3Y CAGR-29%

About

Cohance Lifesciences Limited is a contract development and manufacturing organization (CDMO) and API manufacturer.;
Founded in
2018
NSE symbol
COHANCE

Shareholding pattern

Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Shareholder details

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹23,025.00
+15.00 (0.07%)
L
    H
    29,424.3259.1115.71
    ₹213.20
    -1.20 (0.56%)
    L
      H
      28,550.76--3.5
      ₹1,527.90
      +8.80 (0.58%)
      L
        H
        17,370.65--2.98
        ₹402.05
        +1.30 (0.32%)
        L
          H
          16,183.1073.293.34
          Livesquawk
          Cohance Life saw a Rs 46.35 cr BSE block trade for 1,000,045 shares at Rs 463.5/share.
          Livesquawk
          Goldman Sachs maintains Buy on Cohance with a ₹500 target, citing weak Q1 in Pharma CDMO and Agrochemicals. Recovery is expected from Q2FY27, driven by commercial deliveries, operational normalization, and strategic expansion.
          Livesquawk
          Cohance Lifesciences reports Q1 consolidated net loss of ₹241M. The loss improved compared to ₹489M in the prior year (YoY).
          2026
          5
          Aug
          Quarterly Result
          Release date
          12
          May
          Quarterly & Annual Result
          Release date
          12
          Feb
          Quarterly Result
          Release date
          2025
          12
          Nov
          Quarterly Result
          Release date
          13
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks